Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Racquel Innis-Shelton"'
Autor:
Pashtoon Murtaza Kasi, Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill, Hiba Dada, Regina Resta, Stephanie Wagner, Naomi Fei
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/605590a30d7b4c05973e28dd694297b5
Autor:
Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill, Hiba Dada, Regina Resta, Stephanie Wagner, Naomi Fei, Pashtoon Murtaza Kasi
Publikováno v:
Journal for immunotherapy of cancer. 10(6)
Clinical trials reporting the robust antitumor activity of immune checkpoint inhibitors (ICIs) in microsatellite instability-high (MSI-H) solid tumors have used tissue-based testing to determine the MSI-H status. This study assessed if MSI-H detected
Autor:
Ayman Saad, Racquel Innis-Shelton, Marisa B. Marques, Lawrence S. Lamb, Donna Salzman, Daniel B. Peavey, Antonio Di Stasi, Nicole Watts, Luciano J. Costa
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:233-238
Filgrastim (FIL) is the most common growth factor combined with plerixafor for autologous hematopoietic progenitor cell mobilization, but requires daily, multi-injection administration. We adopted a standardized mobilization regimen with pegfilgrasti
Autor:
Sakti Chakrabarti, Leslie A. Bucheit, Jason S. Starr, Racquel Innis-Shelton, Ardaman Shergill, Regina Resta, Stephanie Ann Wagner, Pashtoon Murtaza Kasi
Publikováno v:
Journal of Clinical Oncology. 40:607-607
607 Background: Immunotherapy (IO) is known to have robust anti-tumor activity in patients with MSI-H solid tumors. However, clinical trials investigating IO activity have used tissue-based testing to determine MSI-H status. Pancreatic tumor biopsy o
Autor:
Ayman Saad, Shin Mineishi, Joseph H. Chewning, Samantha Langford, Rivvi Kukkamalla, Donna Salzman, Rehan Sarmad, Ruby F. Meredith, Alankrita Taneja, Racquel Innis-Shelton, Ravi Bhatia, Vera Hauptfeld, Kirby Ann Plessala, Luciano J. Costa, Antonio Di Stasi, Lawrence S. Lamb
Publikováno v:
Bone Marrow Transplantation. 53:1345-1348
Autor:
Mufti Naeem Ahmad, Sairah Ahmed, Shukaib Arslan, Farrukh T. Awan, Qaiser Bashir, Didier Blaise, Megan Bodge, Stefania Bramanti, Luca Castagna, Luciano J. Costa, Aaron Cumpston, Anita D’Souza, Marcos de Lima, Raynier Devillier, Rebecca Devlin, Fiona L. Dignan, Sabine Furst, Ragisha Gopalakrishnan, Alison Gulbis, Vikas Gupta, Ali Haider, Parameswaran Hari, Chitra Hosing, Mohammed Junaid Hussain, Racquel Innis-Shelton, Madan Jagasia, Abraham S. Kanate, Partow Kebriaei, Maliha Khan, Shakila P. Khan, Mohamed A. Kharfan-Dabaja, Sola Kim, Mira A. Kohorst, Amrita Krishnan, Rohtesh S. Mehta, Muhammad Ayaz Mir, Ravi Kishore Narra, Nhu-Nhu Nguyen, Yago Nieto, Liana Nikolaenko, Amanda Olson, Kelly E. Pillinger, Chelsea C. Pinnix, L.M. Poon, Kelly G. Ross, Muhammad A. Saif, Nirav N. Shah, Zainab Shahid, Bronwen E. Shaw, Elizabeth J. Shpall, Rabbia Siddiqi, Roni Tamari, Benjamin Tomlinson, Saad Zafar Usmani, Lauren Veltri, Daniel Weisdorf, Ibrahim Yakoub-Agha, Lily Yan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6ac12c92007eadfdd5c803223614860
https://doi.org/10.1016/b978-0-323-56802-9.01002-6
https://doi.org/10.1016/b978-0-323-56802-9.01002-6
Hematopoietic cell transplantation is based on the administration of a graft containing hematopoietic progenitor cells with the objective of restoring hematopoiesis after myeloablative chemotherapy and/or radiation, expediting hematologic recovery af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fc82aa27a89db5866a0e5397df3a6ba
https://doi.org/10.1016/b978-0-323-56802-9.00005-5
https://doi.org/10.1016/b978-0-323-56802-9.00005-5
Autor:
Robert F. Cornell, Diego de Idiaquez, Binod Dhakal, Kelly N. Godby, Saurabh Chhabra, Eva Medvedova, Aric C. Hall, Susan Bal, Pamela Hardwick, Natalie S. Callander, Parameswaran Hari, Rebecca Silbermann, Luciano J. Costa, Racquel Innis-Shelton
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S24
Introduction Unprecedented depth of response is obtained with regimens incorporating monoclonal antibodies in the management of newly diagnosed multiple myeloma (NDMM). The incremental benefit of AHCT in this setting is being reconsidered but can be
Autor:
Lauren C. Smith, Antonio Di Stasi, Omer Jamy, Rivvi Kukkamalla, Sejong Bae, Racquel Innis-Shelton, Amber T. McKell, Tiffany Hill, Susan Bal, Emily A. Plews, Ayman Saad, Luciano J. Costa, Lawrence S. Lamb, Donna Salzman, Ravi Bhatia, Daniel B. Peavey
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S178
Introduction Seminal studies of peripheral blood versus bone marrow grafts have elucidated the crucial role of CD3+ T-cells in mediating engraftment, immune reconstitution, disease control, and graft versus host disease (GVHD). An optimal dose-respon
Autor:
Lawrence S. Lamb, Donna Salzman, Luciano J. Costa, Racquel Innis-Shelton, Ayman Saad, Shin Mineishi, Antonio Di Stasi, Omer Jamy, Susan Bal
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S190
Background The optimal regimen for graft versus host disease (GVHD) prophylaxis in matched unrelated donor (MUD) allogeneic hematopoietic stem cell transplantation (HSCT) is not well defined. Post-transplant cyclophosphamide (PT-Cy) mitigates GVHD af